vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Erie Indemnity (ERIE). Click either name above to swap in a different company.

Erie Indemnity is the larger business by last-quarter revenue ($1.0B vs $950.5M, roughly 1.1× Astrana Health, Inc.). Erie Indemnity runs the higher net margin — 14.9% vs 0.7%, a 14.2% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 2.3%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 1.1%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Erie Insurance Group, based in Erie, Pennsylvania, is a property and casualty insurance company offering auto, home, business and life insurance through a network of independent insurance agents. As of 2021, Erie Insurance Group is ranked 347th on the 2021 Fortune 500 list of largest American corporations, based on total revenue for the 2020 fiscal year.

ASTH vs ERIE — Head-to-Head

Bigger by revenue
ERIE
ERIE
1.1× larger
ERIE
$1.0B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+40.6% gap
ASTH
42.9%
2.3%
ERIE
Higher net margin
ERIE
ERIE
14.2% more per $
ERIE
14.9%
0.7%
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
1.1%
ERIE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
ERIE
ERIE
Revenue
$950.5M
$1.0B
Net Profit
$6.6M
$150.5M
Gross Margin
Operating Margin
1.9%
16.5%
Net Margin
0.7%
14.9%
Revenue YoY
42.9%
2.3%
Net Profit YoY
184.4%
8.7%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
ERIE
ERIE
Q1 26
$1.0B
Q4 25
$950.5M
$951.0M
Q3 25
$956.0M
$1.1B
Q2 25
$654.8M
$1.1B
Q1 25
$620.4M
$989.4M
Q4 24
$665.2M
$924.1M
Q3 24
$478.7M
$999.9M
Q2 24
$486.3M
$990.4M
Net Profit
ASTH
ASTH
ERIE
ERIE
Q1 26
$150.5M
Q4 25
$6.6M
$63.4M
Q3 25
$373.0K
$182.9M
Q2 25
$9.4M
$174.7M
Q1 25
$6.7M
$138.4M
Q4 24
$-7.8M
$152.0M
Q3 24
$16.1M
$159.8M
Q2 24
$19.2M
$163.9M
Operating Margin
ASTH
ASTH
ERIE
ERIE
Q1 26
16.5%
Q4 25
1.9%
16.6%
Q3 25
2.0%
19.6%
Q2 25
3.1%
18.8%
Q1 25
3.3%
15.3%
Q4 24
0.1%
18.1%
Q3 24
5.9%
18.0%
Q2 24
6.2%
19.2%
Net Margin
ASTH
ASTH
ERIE
ERIE
Q1 26
14.9%
Q4 25
0.7%
6.7%
Q3 25
0.0%
17.1%
Q2 25
1.4%
16.5%
Q1 25
1.1%
14.0%
Q4 24
-1.2%
16.5%
Q3 24
3.4%
16.0%
Q2 24
3.9%
16.5%
EPS (diluted)
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
$0.12
Q3 25
$0.01
Q2 25
$0.19
Q1 25
$0.14
Q4 24
$-0.14
Q3 24
$0.33
Q2 24
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
ERIE
ERIE
Cash + ST InvestmentsLiquidity on hand
$429.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$2.4B
Total Assets
$2.2B
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
$429.5M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Stockholders' Equity
ASTH
ASTH
ERIE
ERIE
Q1 26
$2.4B
Q4 25
$779.3M
$2.3B
Q3 25
$775.5M
$2.3B
Q2 25
$765.5M
$2.2B
Q1 25
$745.4M
$2.1B
Q4 24
$712.7M
$2.0B
Q3 24
$704.6M
$1.9B
Q2 24
$678.9M
$1.8B
Total Assets
ASTH
ASTH
ERIE
ERIE
Q1 26
$3.4B
Q4 25
$2.2B
$3.4B
Q3 25
$2.2B
$3.3B
Q2 25
$1.4B
$3.1B
Q1 25
$1.3B
$3.0B
Q4 24
$1.4B
$2.9B
Q3 24
$1.3B
$2.9B
Q2 24
$1.3B
$2.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
ERIE
ERIE
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
$-2.9M
$171.6M
Q3 25
$10.0M
$219.4M
Q2 25
$90.9M
$177.6M
Q1 25
$16.6M
$118.1M
Q4 24
$-10.9M
$193.5M
Q3 24
$34.0M
$199.2M
Q2 24
$23.2M
$131.4M
Free Cash Flow
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
$-6.0M
$140.8M
Q3 25
$7.4M
$184.4M
Q2 25
$89.5M
$157.3M
Q1 25
$13.6M
$88.4M
Q4 24
$-13.5M
$146.8M
Q3 24
$31.7M
$171.5M
Q2 24
$20.4M
$103.4M
FCF Margin
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
-0.6%
14.8%
Q3 25
0.8%
17.3%
Q2 25
13.7%
14.8%
Q1 25
2.2%
8.9%
Q4 24
-2.0%
15.9%
Q3 24
6.6%
17.1%
Q2 24
4.2%
10.4%
Capex Intensity
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
0.3%
3.2%
Q3 25
0.3%
3.3%
Q2 25
0.2%
1.9%
Q1 25
0.5%
3.0%
Q4 24
0.4%
5.0%
Q3 24
0.5%
2.8%
Q2 24
0.6%
2.8%
Cash Conversion
ASTH
ASTH
ERIE
ERIE
Q1 26
Q4 25
-0.44×
2.71×
Q3 25
26.69×
1.20×
Q2 25
9.65×
1.02×
Q1 25
2.48×
0.85×
Q4 24
1.27×
Q3 24
2.11×
1.25×
Q2 24
1.21×
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

ERIE
ERIE

Management fee revenue - policy issuance and renewal services$786.4M78%
Administrative services reimbursement revenue$200.1M20%
Management fee revenue - administrative services$19.5M2%
Service agreement revenue$5.9M1%

Related Comparisons